Minimally-Invasive Mitral Valve Repair With Creation of Artificial Cordae Tendonae for Mitral Regurgitation - European Reimbursement Report

  • ID: 4243317
  • Report
  • Region: Europe
  • European Med Tech Reimbursement Consulting AB
1 of 4
Essential Information About Reimbursement and National Funding of the Minimally-Invasive Mitral Valve Repair With Creation of Artificial Cordae Tendonae for Mitral Regurgitation

Report presents summary of the reimbursement situation for a specific minimally invasive mitral valve repair procedure with creation of artificial cordae tendonae. The technology is intended to support natural chordae tendonae, when it is ruptured or elongated as a consequence of the degenerative valve disease.

Report includes essential information about reimbursement and national funding of the minimally-invasive mitral valve repair with creation of artificial cordae tendonae for mitral regurgitation, including:

  • Brief overview of reimbursement system for medical devices
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions in indications or scenarios for use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following countries:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • France
  • Germany
  • Italy
  • Netherlands
  • Norway
  • Sweden
  • Switzerland
Note: Product cover images may vary from those shown
2 of 4

1. Introduction and summary

2. Executive summary table

3. Contents

4. Methodology

5. Reimbursement analysis in Austria
5.1. Overview of the reimbursement system
5.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae

6. Reimbursement analysis in Belgium
6.1. Overview of the reimbursement system
6.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae

7. Reimbursement analysis in Denmark
7.1. Overview of the reimbursement system
7.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae
7.2.1. Procedure coding
7.2.2. Diagnosis coding
7.2.3. Payment mechanism and reimbursement tariffs

8. Reimbursement analysis in England
8.1. Overview of the reimbursement system
8.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae
8.2.1. Procedure coding
8.2.2. Diagnosis coding
8.2.3. Payment mechanism and reimbursement tariffs
8.2.4. Policy considerations
8.2.4.1. National commissioning by NHS England

9. Reimbursement analysis in France
9.1. Overview of the reimbursement system
9.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae
9.3. Coverage with evidence development
9.3.1. Minimally invasive mitral valve repair with creation of artificial chordae tendonae for mitral regurgitation

10. Reimbursement analysis in Germany
10.1. Overview of the reimbursement system
10.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae
10.2.1. Procedure coding
10.2.2. Diagnosis coding
10.2.3. Payment mechanism and reimbursement tariffs
10.2.4. Policy considerations

11. Reimbursement analysis in Italy
11.1. Overview of the reimbursement system
11.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae
11.2.1. Procedure coding
11.2.2. Diagnosis coding
11.2.3. Payment mechanism and reimbursement tariffs at national level
11.2.4. Payment mechanism and reimbursement tariffs at regional level

12. Reimbursement analysis in the Netherlands
12.1. Overview of the reimbursement system
12.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae

13. Reimbursement analysis in Norway
13.1. Overview of the reimbursement system
13.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae
13.2.1. Policy considerations

14. Reimbursement analysis in Sweden
14.1. Overview of the reimbursement system
14.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae
14.2.1. Procedure coding
14.2.2. Diagnosis coding
14.2.3. Payment mechanism and reimbursement tariffs

15. Reimbursement analysis in Switzerland
15.1. Overview of the reimbursement system
15.2. Reimbursement for minimally invasive mitral valve repair with creation of artificial chordae tendonae
15.2.1. Procedure coding
15.2.2. Diagnosis coding
15.2.3. Payment mechanism and reimbursement tariffs

16. Disclaimer

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Harpoon Medical (Harpoon Medical device)
  • Neochord (NeoChord DS1000 System)
  • TransCardiac Therapeutics (MitraFlex system)
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll